Wellcome Sanger Institute joins Biohub’s global Virtual Biology Initiative
The Wellcome Sanger Institute has joined a major new international effort to build the open data foundations needed to accelerate artificial intelligence–driven biology and biomedical discovery
The Wellcome Sanger Institute, based at the Wellcome Genome Campus, has joined a new Virtual Biology Initiative led by Biohub, a nonprofit research organisation. The initiative, a landmark five‑year programme backed by a $500 million commitment from Biohub, aims to unite global efforts to develop new technologies and large, multi-type datasets to build accurate models of human cells to accelerate efforts to cure and prevent disease.
The Virtual Biology Initiative brings together leading scientific institutions to address one of the central challenges in modern biology: the need for orders of magnitude more high‑quality data than currently exists in order to build predictive models of cellular behaviour. These models have the potential to transform understanding of health and disease, enabling researchers to test hypotheses digitally and accelerate scientific discovery far beyond what is possible through laboratory experimentation alone.
As part of the initiative, Biohub is committing $100 million to help establish a coordinated, worldwide data‑generation effort involving multiple institutions, alongside a further $400 million investment to develop next‑generation technologies for measuring, imaging, and engineering biology at scale. All data generated through the initiative will be made openly and freely available to the global scientific community.
The Wellcome Sanger Institute is among the organisations working with Biohub to coordinate this broader global effort, including the Allen Institute, the Arc Institute, and the Broad Institute. Sanger scientists have played key roles in previous internationally collaborative initiatives including the Human Genome Project and the Human Cell Atlas, and the organisation is widely recognised for its longstanding commitment to open science and large‑scale data sharing.
Commenting on the announcement, Dr Nicole Mather, Chair of the Wellcome Genome Campus’ Science & Tech Advisory Group, said:
“We are delighted that the expertise based on the Wellcome Genome Campus will play a key role in the development of this important collaboration to power the future of AI- accelerated biology. As our campus expands, we look forward to continuing to play a leading role in major global initiatives which safely make data available to drive forward scientific discovery.”
Read the full announcement on Biohub’s website:
